American Ginseng Supplementation Does Not Attenuate Indices of Exercise Induced Muscle Damage by Smith, Brent
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
October 2014 
American Ginseng Supplementation Does Not Attenuate Indices 
of Exercise Induced Muscle Damage 
Brent Smith 
The University of Western Ontario 
Supervisor 
Dr. Peter Lemon 
The University of Western Ontario 
Graduate Program in Kinesiology 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Brent Smith 2014 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Other Medicine and Health Sciences Commons 
Recommended Citation 
Smith, Brent, "American Ginseng Supplementation Does Not Attenuate Indices of Exercise Induced 
Muscle Damage" (2014). Electronic Thesis and Dissertation Repository. 2464. 
https://ir.lib.uwo.ca/etd/2464 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
  
 
 
American Ginseng Supplementation Does Not Attenuate Indices of Exercise- 
Induced Muscle Damage 
 
 
(Thesis format: Monograph) 
By 
Brent E. Smith 
 
Graduate Program in Kinesiology 
 
A thesis submitted in partial fulfillment  
of the requirements for the degree of  
Master of Science 
 
The School of Graduate and Postdoctoral Studies 
 
Western University 
London, Ontario, Canada 
© Brent E. Smith 2014 
 
 
 
i 
  
 
 
ABSTRACT 
PURPOSE: To investigate the effect of American ginseng consumption on changes in average 
peak torque measures of dominant leg extensors following a downhill running bout. 
METHODS: Ten university aged male volunteers were divided equally into two groups in this 
double-blind study.  Both groups performed baseline tests to determine average peak torque of 
leg extensors. Subjects then began a 4 week supplementation period of American ginseng or 
placebo. They then performed a downhill treadmill run at a speed between 9.7-11.3 km/h and -
12% grade. The muscle strength protocol involving the dominant leg extensors was then repeated 
at one, two, and three days following the downhill run. RESULTS: There was no group by time 
interaction effect for the isometric (p=0.182), isokinetic at 60 d/s (p=0.542), nor the isokinetic at 
180 d/s (p=0.893). CONCLUSION: 4 weeks of American ginseng consumption prior to 
downhill running was unable to attenuate post-exercise reductions in muscle strength.  
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CHAPTER 1- INTRODUCTION 
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Ginseng is part of the plant family Araliaceae and its species in the genus Panax (Helms. 
2004; Bames et al. 2004). The name ginseng is derived from the Chinese words “Jen Sheng”, 
meaning “man-herb,” because the root or rhizome of the plant (the part of the plant most often 
consumed) has a humanoid shape (Lü et al. 2009). Furthermore, the name Panax means “all 
healing,” which portrays the traditional belief that ginseng has the ability to act as a “cure all” for 
all aspects of the body (Lü et al. 2009).  Currently, ginseng is one of the best-selling medicinal 
plants in the world (Yun. 2001). 
In Asian countries, ginseng root has been used for thousands of years in the traditional 
medicine system (Ang-Lee et al. 2001; Attele et al. 1999; Wang and Yuan. 2008) to benefit 
health and treat illness (Bensky et al. 1993). Ginseng, has been used as a tonic, prophylactic 
and/or ‘restorative’ agent (Goldstein. 1975; Hu. 1977; Liu and Xiao. 1992).  According to 
Western botanical medicine texts from the 1800s and early 1900s, ginseng acts as both a mild 
sedative and stimulant useful for nerves and exhaustion, is used to increase circulation, and to 
treat dyspepsia (upset stomach or indigestion) (King. 1878; Ellingwood. 1915). Also, ginseng 
has been used to treat nervous disorders, anemia, wakefulness, shortness of breath, excess 
perspiration, forgetfulness, continuous thirst, lack of sexual desire, acute and chronic fatigue, and 
angina (Brekhman and Dardymov. 1969; Cartwright. 1979; Hu. 1976; Li and Li; 1973; Perry and 
Metzger. 1980). Furthermore, ginseng has been ingested as a preventative measure to protect 
against the effects of aging, fatigue, headaches, amnesia, tuberculosis, diabetes mellitus, and 
illnesses of the liver, heart and kidneys, (Baranov. 1966; Bittles et al.1979; Popov and Goldwag. 
1973). Ginseng has also even been given to improve job-related efficiency involving physical 
labour (Perry and Metzger. 1980).   
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The most common forms of ginseng are Asian ginseng (Panax ginseng C.A. Meyer, 
named for Russian scientist Carl Anton Meyer in 1843 [Yun. 2001]) and American ginseng, 
which is also known as Panax quinquefolius L. (Lü et al. 2009). Asian ginseng is widely used 
and has been studied extensively (Ang-Lee et al. 2001; Yun. 2001) but the literature on 
American ginseng is rather limited (Yuan et al. 2004).  
In the USA, ginseng is among the most regularly purchased herbs (Blumenthal. 2002). In 
fact, in 2002, a national survey of men and women concluded that 4-5% of people between the 
ages of 45-64 years consumed ginseng (Kaufman et al. 2002). Further, two Canadian surveys 
found that 17-32% of patients with cardiovascular disease used herbs and 6% of the people who 
were using herbs consumed ginseng (Pharand et al. 2003; Wood et al. 2003). 
  As the names suggest, Asian ginseng is grown in China, Korea, Japan, and Russia 
primarily (Helms. 2004) but also in Germany (Yun. 2001).  American ginseng is native to North 
America (Borchers et al. 2000) but due to its popularity is cultivated worldwide (Li and Mazza. 
1999).  According to Agriculture and Agri-Food Canada, Canada is the world’s largest producer 
of American ginseng with Simcoe, Ontario accounting for much of Canada’s production with the 
rest being grown primarily in British Columbia. The other primary growing areas for American 
ginseng include Wisconsin in the United States as well as the northeast and northern areas of 
China (Agriculture and Agri-Food Canada). 
Recent data suggest that American ginseng, similar to its Asian relative, has a variety of 
pharmacological actions (Qi et al. 2011).  Antioxidant, anti-inflammatory, and immune-
stimulatory activities are often suggested as the potential mechanisms responsible for the effects 
of ginseng (Qi et al. 2011). Specifically, American ginseng has been reported to have beneficial 
effects on the central nervous, cardiovascular, endocrine, and immune systems, and even to play 
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a role in cancer prevention (Court. 2000; Jin et al. 2010; Li et al. 2010a; Yuan and Dey. 2001) 
perhaps by inhibiting tumour cell growth (Qi et al. 2010b, Wang et al. 2007a, Wang et al. 
2009b).  Apparently, the ginsenosides (or ginseng saponins) are the major pharmacologically 
active ingredients in ginseng, promoting most of its actions including vasorelaxation, anti-
oxidation, anti-inflammation and anti-cancer effects (Lü et al. 2009).  
The ginsenoside profile that American ginseng possesses differs from that of its Asian 
relative in terms of the total number of ginsenosides, the ratio of protopanaxadiol (PPD) to 
protopanaxatriol (PPT), and other marker ginsenosides (Qi et al. 2011). In fact, the ginsenoside 
content in American ginseng is greater than other species of ginseng including Asian ginseng 
(Dharmananda. 2002). It has been suggested that the large variability in the ginsenoside content 
amongst different species and batches may play a role in the equally high variability in efficacy 
observed (Vuksan and Sievenpiper. 2005). Reports regarding the effectiveness of ginseng often 
contradict one another and this may be due to the differing chemical composition of ginseng root 
or root extracts, the method of extraction, subsequent handling, or even the season of its 
collection (Qi et al. 2011). For instance, when five batches of Ontario-grown American ginseng 
from five different farms were tested to evaluate their ability to reduce to reduce postprandial 
glycemia in healthy individuals, 60% the batches were able to exert glucose-lowering effects, yet 
40% of did not reduce glucose to the degree that was anticipated. (Dascalu et al. 2007). 
Nevertheless, American ginseng with a similar makeup could have similar physiological effects 
(Qi et al. 2011). Consequently, one could speculate that any two ginseng batches of similar 
profiles could produce similar efficacy.  
In addition to these numerous reported benefits, there are also data that have shown 
supplementation with American ginseng in humans to be effective in attenuate circulating 
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creatine kinase, a marker of muscle damage, both during and at various time points following a 
bout of aerobic exercise (Hsu et al. 2005). Similarly, Asian ginseng can reduce plasma creatine 
kinase concentration following an aerobic exercise session (Jung et al. 2011). This suggests that 
ginseng (both American and Asian) might be useful as a recovery agent following exercise, since 
they may be able to attenuate exercise induced muscle damage, which in turn, could allow 
athletes to tolerate a greater training load, which may result in improved exercise performance. 
Nevertheless, the human data that exist on American ginseng and its relationship to post-exercise 
muscle damage attenuation is rather limited. Thus, there is the opportunity to explore this area of 
research and to formulate new ideas and knowledge pertaining to this topic. The aim of this 
thesis was to assess the effects of American ginseng on muscle damage using a more definitive 
outcome measure (muscle strength) that has not been used extensively in past ginseng studies.  
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CHAPTER 2- REVIEW OF LITERATURE 
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Much has been written about ginseng.  As mentioned earlier, ginseng has an extensive 
history and is today one of the most commonly used medicinal plants worldwide (Qi et al. 2011). 
It has been reported to exert many beneficial physiological effects including vasorelaxation, anti-
oxidation, anti-inflammation and anti-cancer (Lü et al. 2009). Some recent research has used 
purified individual ginsenosides to uncover the mechanism of action of ginseng as opposed to 
using ground up ginseng root which is far more typical (Buetnner et al. 2006; Gillis. 1997; 
Hofseth and Wargovich. 2007; Attele et al. 1999; Zhou et al. 2004; Cheng et al. 2005). This may 
be critical because it has been suggested that each individual ginsenoside has different 
pharmacologic effects due to its dissimilar structure (Lü et al. 2009). 
One area of ginseng research that is rather limited is the effect of ginseng ingestion 
(especially American ginseng) on exercise-induced skeletal muscle damage in humans. This 
chapter reviews the ginseng literature in detail, including a brief synopsis of its history, the 
different varieties of ginseng, the various ginsenosides, (the major pharmacologically active 
ingredients in ginseng), and the link between ginseng and exercise-induced muscle damage.  In 
addition, because muscle damage is a major component of this study, an overview of the 
literature on exercise-induced damage is also provided. Finally, information is presented on 
certain nutritional supplements and their ability to limit muscle damage, the repeated bout effect 
(prolonged protective effect of a single bout of eccentric exercise), and the methodology used 
typically to assess muscle damage.   
2.1 Brief History of Ginseng 
As mentioned, ginseng has an extensive history related to a wide variety of physical 
ailments. The origin of ginseng dates back to prehistoric times (Yun. 2001). In China, Shennong 
(Divine Peasant), who was also known as the Emperor Yan, the Yellow Emperor, or one of the 
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“Three Emperors,” was reported to have tasted a large number of plants resulting in the 
discovery of several medicinal herbs (Zheng. 1985). Dates of the original work are unclear but 
studies conducted by Shennong passed down by way of mouth over generations were amassed 
into a book entitled, “Shennong Bencao Jing (Shennong’s Herbal)” by Tao Hongjing during the 
Liang Dynasty, 502-557 AD (Wang. 1987). Apparently, there are 365 types of herb listed, 
separated into three categories based on their degree of toxicity (Yun. 2001). The best ones are 
non-toxic and reportedly can bolster vital energy when used consistently (Yun. 2001). Radix 
ginseng (a derivative of Asian ginseng), was an example of one of these “superior” herbs (Yun. 
2001). Moreover, ginseng was mentioned by Chinese native, Shi You, in a piece of literature 
entitled, “Jijuzhang (Interpretation of Creatures)” between 48 and 33 BC and prescriptions for 
ginseng can be found in “Shanghan Lun (Treatise on Fevers)” between the years 196 and 200 
AD (Yun. 2001). 
Today, ginseng is very popular and it is cultivated in various places throughout the world. 
In 1999, it was reported that over 3000 hectares are cultivated in Canada, primarily in Ontario 
and British Columbia (Li and Mazza. 1999). Ginseng can be purchased over the counter without 
a prescription and ginseng products are available commercially in a variety of forms, such as, 
roots, tablets and capsules, liquid extracts, and even in carbonated drinks and teas (Jia and Zhao. 
2009). 
2.2 Types of Ginseng 
At least thirteen species of ginseng exist including: Panax japonicas (Japanese ginseng), 
cultivated in Japan, Panax major Ting, Panax notoginseng (Burkill) F.H. Chen (Sanchi ginseng), 
grown in China’s Yunnan province, Panax omeiensis J Wen, Panax pseudoginseng Wallich, 
found in Nepal and the eastern Himalayas, Panax sinesis J Wen, Panax stipuleanatus H. T. Tsai 
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& K.M. Feng, Panax trifolius L. (Dwarf ginseng), from Nova Scotia to Wisconsin and further 
south, Panax wangianus Sun, Panax zingiberensis C.Y. Wu & K.M. Feng, Panax vietnamensis 
Ha et Grushv (Vietnamese ginseng), Panax quinquefolius L. (American  ginseng), and Panax 
ginseng C.A. Meyer (Yun. 2001). Panax quinquefolius L. is also called North American ginseng 
(Qi et al. 2011) and likewise, Panax ginseng C.A. Meyer is also called Asian, Korean or Chinese 
ginseng (Qi et al. 2011). Although Asian ginseng may refer to any ginseng grown in an Asian 
country (Yun. 2001), for the purposes of this thesis, when Asian ginseng is mentioned it means 
Panax ginseng C.A. Meyer. 
 There is also Siberian or Russian ginseng and while some claim that it has similar effects 
to other ginseng products, it is not derived from the Panax genus (Donovan et al. 2003) and is 
instead a totally different plant called Eleutherococcus senticosus (Baranov. 1982; Brekhman. 
1965). Thus, it is not considered a “true” ginseng (Donovan et al. 2003) even though it is derived 
from the same family (Araliaceae) as American, Asian and other “true” ginsengs (Davydov and 
Krikorian. 2000). Although Siberian ginseng does not contain any ginsenosides (Brekhman. 
1965; Cui et al. 1995), it does contain eleutherosides (Elyakov et al. 1964) and other chemical 
components that have been reported to induce some beneficial pharmacological actions 
(Davydov and Krikorian. 2000). However, the eleutherosides have a chemical structure that is 
entirely different from the ginsenosides (Bahrke and Morgan. 2000). Several of the reported 
physiological actions of Siberian ginseng, sometimes used as a less expensive alternative to 
Panax ginseng C.A. Meyer in the former Soviet Union and other countries as well (Bahrke and 
Morgan. 2000), are similar to that of “true” ginseng from the Panax genus such as, anti-cancer 
and immunostimulatory effects as well as anti-inflammatory and antioxidant effects (Davydov 
and Krikorian. 2000).  
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 Unlike Siberian ginseng, Panax japonicus C.A. Meyer, also known as Japanese ginseng, 
is considered a “true” ginseng as it belongs to the Panax genus and thus, contains ginsenosides 
(Bahrke and Morgan. 2000). It is cultivated in Japan mainly, but also in India and Southern 
China (Phillipson and Anderson. 1984; Court. 1975; Williams. 1957). In Japan, it also has been 
used as an alternative to Panax ginseng C.A. Meyer to treat gastrointestinal disorders and also as 
an antitussive, expectorant and antipyretic (Bahrke and Morgan. 2000). 
 Panax ginseng C.A. Meyer or Asian ginseng was originally called Panax schinseng Nees 
in 1833 after the German botanist Nees van Esenbeck (Yun. 2001). Later, in 1843, it was 
renamed Panax ginseng C.A. Meyer after the Russian scientist Carl Anton Meyer (Yun. 2001). 
The production of Asian ginseng dates back to around 11 BC in Korea by transplantation of wild 
ginseng (Yun. 2001). Asian ginseng grown in Korea is said to be harvested following four to six 
years of cultivation and subsequently categorized into three forms depending on how it is 
processed (Yun. 2001).  The three forms are fresh ginseng, harvested when it is less than four 
years old and consumed fresh, white ginseng, harvested when it is between four to six years old 
and then dried after being peeled, and red ginseng, harvested when it is six years old and then 
subsequently steamed and dried (Yun. 2001). Additionally, sun ginseng, which is white ginseng 
that has been steamed at 120 degrees Celsius (Kasai et al. 1983; Kwon et al. 2001), is sometimes 
considered to be another form of Panax ginseng that exhibit more powerful pharmacological 
effects, including vasorelaxation, antioxidant, and antitumor activities when compared to 
standard white or red ginseng (Keum et al. 2000; Kim et al. 2000).  
In the traditional Chinese system of medicine, red ginseng has been utilized to help 
remedy physical ailments such as weak constitution, ulcers, cold symptoms, anemia as well as an 
analeptic (central nervous system stimulant), a stomachic (improves appetite and digestion) and 
11 
 
 
 
an erythropoietic (Matsuda et al. 1986).   Importantly, extracts of red and white ginseng possess 
different ginsenosides (Chong and Oberholzer. 1988). To ensure high quality ginseng, the plant 
needs to be harvested in the fall season and never before five or six years of growth (Popov and 
Goldwag. 1973). For instance, ginseng roots may yield four ginsenosides initially, following five 
or six years of cultivation, they may yield up to nine ginsenosides (Liberti and Der Marderosian. 
1978). However there is some debate because in Japan, it is believed the ginsenoside content in 
Asian ginseng nears maximum in the late summer following four years of cultivation (Soldati 
and Tanaka. 1984). Asian ginseng, the most widely recognized and researched form of ginseng, 
has been shown to induce a variety of beneficial physiological effects on health and well-being.  
Like Asian ginseng, American ginseng (Panax quinquefolius L.) is another widely 
recognized type of ginseng, but it is not as well studied as its Asian relative (Yuan et al. 2004). It 
was discovered in 1716 near Montreal, Quebec (Evans. 1985) and has been utilized since as an 
energy booster and/or to achieve a sense of well-being (Li. 1995). It is advertised to have 
adaptogenic (an adaptogen is something that helps the body counteract stress and attain 
homeostasis) properties and has been used as an analeptic, tonic, stomach pain analgesic, and 
even as an aphrodisiac (Liberti and Der Marderosian. 1978).   
There are three types of American ginseng available: cultivated, simulated wild and wild 
(Yuan et al. 2010). Most of the wild American ginseng flourishes in the upland, north- and east-
facing woods because it is there where shade and loam soils are located (Yuan et al. 2010).    
Interestingly, American ginseng has now begun to be grown in some Asian countries, such as 
China (Yuan et al. 2010).   
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2.3 Aqueous and Alcohol Extracts of Ginseng 
 Although alcohol and aqueous extraction processes are available resulting in differing 
gensenoside content, often ginseng is ingested as ginseng root powder.  Interestingly, a study 
using male Wistar rats found that while both aqueous and alcohol extracts of American ginseng 
attenuated rises in blood creatine kinase, only the aqueous extract was able to reduce 
morphological signs of damage and inflammation (Estaki and Noble. 2012). The prevention of 
rises in blood creatine kinase was thought to be due to the ginsenosides and their ability to 
enhance sarcolemma stability thus, preventing a disturbance to the membrane. Moreover, it was 
speculated  that polysaccharides that are only found in the aqueous extract possess 
immunosuppressant characteristics and are able to limit the over activation of white blood cells, 
which may have explained the superior ability of the aqueous extract to protect against muscle 
damage when compared to the alcohol extract of American ginseng. (Estaki and Noble. 2012). 
Furthermore a previous study in humans showed that American ginseng supplementation was 
able to attenuate rises in plasma creatine kinase induced by an exhaustive running protocol when 
the subjects consumed, what appears to be an aqueous extract evidenced by the phrase, “the 
Panax bearing ginsenosides content was determined from its degree of concentration in a hot 
water extract” (Hsu et al. 2005).  
 A study conducted by Azike et al. (2011), described the preparation of aqueous and 
alcohol extracts of ginseng. They mentioned how samples were ground and used to produce 
either the aqueous or alcohol extract and that the ginseng roots were soaked three times during a 
five hour period in 16 litres of water or an ethanol/water solution at 40 degrees Celsius. After the 
extraction, the solution underwent filtration at room temperature and the excess solvent was 
removed via a rotary evaporator under vacuum at 45 degrees Celsius. After the concentration 
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process was completed, the concentrates were freeze-dried at -50 degrees Celsius to produce the 
aqueous or alcohol ginseng in powdered form. Later analysis revealed that the alcohol and 
aqueous extract contained 28.25% and 13.87% of dry weight of extract respectively (Azike et al. 
2011). Typically, the percent ginsenoside yield in ginsengs available for purchase is in the single 
digits. Originally, the plan for the present study was to study the aqueous extract used by Estaki 
and Noble (2012); however, this was not possible as it has not be approved for human use.   
Consequently, powdered American ginseng root grown in Canada that had not undergone any 
extraction procedure was obtained commercially (American Ginseng Vegi Capsules from 
Rootalive) and used in the present thesis. Its total ginsenoside content was 5.53% but, despite 
repeated requests to the manufacturer, the individual ginsenosides it contained was not available.   
2.4 Ginsenosides 
 The majority of the beneficial physiological effects of ginseng, such as vasorelaxation, 
anti-oxidation, anti-inflammation and anti-cancer, have been attributed to its ginsenosides, the 
major pharmacologically active ingredients in ginseng (Lü et al. 2009). The ginseng root has 
been shown to hold 2-3% ginsenosides including Rg1, Rc, Rd, Re, Rb1, Rb2, and Rb0 (Lü et al. 
2009). In excess of 40 ginsenosides or ginseng saponins have been identified and subsequently 
isolated from the root of Panax ginseng (Cheng et al. 2005; Nah. 1997). American ginseng has a 
greater ginsenoside content as more than 60 ginsenosides have been identified from various parts 
of Panax quinquefolius L., including the roots, leaves, stems, flower buds and berries 
(Christensen, 2009; Jia and Zhao. 2009; Jiang et al. 2008; Nakamura et al. 2007; Qu et al. 2009; 
Yoshikawa et al. 1998).  
 The majority of ginsenosides are steroids as they possess a four trans- ring rigid steroid 
skeleton (Attele et al. 1999; Wang et al. 2005) with sugar moieties attached (Cheng et al. 2005; 
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Nah. 1997). They share a triterpenoid saponin structure that is of the dammarane variety 
(Fuzzati. 2004) and are able to be differentiated from one another by the type of sugar moieties, 
sugar number, and site of sugar attachment at positions at carbon-3, carbon-6, or carbon-20 
(Yuan et al. 2010). Isomerism, both structural and stereoisomerism, as well as the quantity and 
site of attachment of hydroxyl groups and available modified side chain at carbon-20 all act to 
further distinguish ginsenosides from each other (Yuan et al. 2010).  
 The ginsenosides from ginseng are separated into a variety of groups with 
protopanaxadiol (PPD) and protopanaxatriol (PPT) being the two major groups and ocotillol and 
oleanane groups are considered minor ones (Figure 1) (Qu et al. 2009; Wang et al. 2005). 
Moreover, dammarane saponins with a slightly altered steroid skeleton have been categorized as 
minor ginsenosides in Panax quinquefolius L. (Nakamura et al. 2007; Yoshikawa et al. 1998). 
Other isolated constituents are subdivided into nine different groups based on variations in the 
carbon-20 side chain (Jiang et al., 2008; Nakamura et al., 2007; Qiu et al., 2009). The PPD group 
has sugar moieties connected to the β-OH at carbon-3 and/or carbon-20, and the PPT group has 
sugar moieties attached to the α-OH at carbon-6 and/or β-OH at carbon-20 (Jia and Zhao. 2009; 
Christensen. 2009; Wang and Yuan. 2008).  The ocotillol group possesses a five-membered 
epoxy ring at C-20 and the oleanane group has a modified C-20 side chain (Yoshikawa et al. 
1998).  
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Figure 1. Core chemical structure of four groups of ginsenosides from ginseng, i.e., 
protopanaxadiol (PPD) group, protopanaxatriol (PPT) group, ocotillol group, and oleanane 
group. Ginsenoside Rf (in square) only exists in Asian ginseng, and pseudoginsenoside F11 (in 
circle) is only found in American ginseng. Glc is an abbreviation for glycopyranoside (Mogil et 
al. 1998) while rha refers to a rhamnose sugar (Lü et al. 2009) with the R standing for the side 
chain.  Figure from (Yuan et al. 2010). 
 
 From a chemical standpoint, there are several methods used to differentiate American 
ginseng from Asian ginseng (Yuan et al. 2010).  One difference is that in Asian ginseng, the 
ginsenoside Rf is present, but in American ginseng it is absent (Shin et al. 2006). Conversely, 
pseudoginsenoside F11 is present in American ginseng but not in the Asian variety (Shin et al. 
2006). Another mechanism used to distinguish between these two types of ginseng is the ratio of 
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Rg1 to Rb1 as well as the ratio of Rb2 to Rb1 (Rg 1, Rb1, Rb2, and Rb1 are in all types of 
ginsenosides) (Yuan et al. 2010).  When both ratios are under 0.4 it is typical of American 
ginseng while a greater value of these ratios is characteristic of Asian ginseng (Nakamura et al. 
2007).  Wild American ginseng is one exception because it can have a high Rg1 to Rb1 ratio 
(Schlag and McIntosh. 2006).    
As for the bioavailability of ginsenosides, it has been suggested that the availability of 
intact ginsenosides as well as their metabolites in the intestines is very low (Karikura et al. 1990; 
Takino. 1994; Xu et al. 2003). For instance, a mere 3.29% of Rg1 and a minuscule 0.64% of Rb1 
were identified in rat serum following ginsenoside ingestion (Han and Fang. 2006; Han et al. 
2006). There was no measurable Rg1 in rat serum 24 hours following consumption while Rb1 
concentration declined at a much slower rate and stayed fairly stable for 72 hours (Xu et al. 
2003). It has been shown that the bioavailability of some ginsenosides can be enhanced by co-
administrating them with adrenaline (Xiong et al. 2009) or by emulsifying those ginsenosides 
into a lipid based substance (Xiong et al. 2008; Han et al. 2009). Suppression of the p-
glycoprotein efflux system has also been shown to increase the bioavailability of some 
ginsenosides (Xie et al. 2005).  As for the half-life of ginsenosides, it has been said to be less 
than 24 hours in humans (Vuksan. 2007).   
The quantity of ginsenosides in American ginseng, like the Asian variety, differs 
depending on the part of the plant (Yuan et al. 2010).  The greatest ginsenoside content is found 
in the leaf (16.5 %), followed by root-hair (6.9%), rhizome (5.1%), root (4.9%) and stem (2.0%) 
(Qu et al. 2009). Further, in all parts of the plant other than the leaf, the quantity of ginsenosides 
increases with age (Zhang et al. 2008). Generally speaking, the key ginsenosides in American 
ginseng are Rb1, Re, Rd, Rc, Rg1, and Rb3 as they are responsible for more than 70% of the total 
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ginsenoside concentration in Panax quinquefolius L. (Qu et al. 2009; Wang et al. 2005; Lim et al. 
2005). It has been suggested that Rb1, Re, and Rd are the major ginsenosides in American 
ginseng and Rb1, Rg1, and Rb2 are the major ginsenosides in Asian ginseng (Qi et al. 2011). 
Nevertheless, variability in individual ginsenosides as well as total ginsenoside concentration 
does exist and has been seen in various commercial products of American ginseng (Lim et al. 
2005; Lin et al. 2010). Moreover, in addition to the age of the plant, there are other factors that 
impact the ginsenoside quantity including root dry weight (Wills et al. 2002), soil fertility (Li 
and Mazza. 1999), light exposure (Fournier et al. 2003), season (Kim et al. 1981; Li and Wardle. 
2002) as well as geography/location (Li et al. 1996; Mudge et al. 2001; Yuan et al. 2001).  This 
variability in ginsenoside content in various ginseng products could also be the reason for the 
different and sometimes contradictory physiological effects observed (Sengupta et al. 2004), 
which illustrates how crucial the standardization of ginseng products is (Yuan et al. 2010). 
Through the use of heating or steaming, American red ginseng can be prepared in such a 
way so that it resembles Korean or Asian red ginseng (Wang et al. 2007). In fact, the chemical 
makeup of steamed American ginseng differs quite a bit from the non-steamed version (Yuan et 
al. 2010). As a result of the alteration in the ginsenoside makeup, the steaming treatment could 
boost some effects of American ginseng, such as enhancing its anti-cancer properties (Wang et 
al. 2007; Wang et al. 2006). 
 
2.5 Ginseng and Muscle Damage  
There are data to imply that it may be of assistance in recovery from exercise, 
specifically, in attenuating exercise-induced muscle damage, which is the basis for this thesis. 
Specifically, four weeks of American ginseng intake (1600 mg daily) in humans (cross-over 
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study) attenuated plasma creatine kinase, a marker commonly used to assess muscle damage, 
both during and following an exhaustive treadmill test at 80% VO2max (Hsu et al. 2005). 
However, there was no improvement in a time to exhaustion treadmill test.   It was hypothesized 
that the reduction in plasma creatine kinase was because of the ability of American ginseng to 
limit the amount of damage to the skeletal muscle cell membrane. While these data suggest that 
American ginseng may be an effective recovery aid following exercise, it did not utilize muscle 
strength measures. It has been suggested in the literature that reductions in muscle strength are 
one of the best indirect measures to denote muscle damage (Warren et al. 1999). In fact, several 
previous studies have pointed out that the emergence of muscle proteins in the blood is not a 
relevant marker of tissue damage (Van der Meulen et al. 1991; Kuipers. 1994; Komulainen et al. 
1995). 
Asian ginseng, specifically Korean red ginseng extract, has also been shown to attenuate 
exercise-induced muscle damage, markers of inflammation, as well as to enhance insulin 
sensitivity (Jung et al. 2011). In this study, 18 male college students consumed 20 g of ginseng 
three times per day or placebo for 11 days (seven days prior to a muscle damaging protocol, 
which was a high-intensity uphill treadmill run, and four days after). The ginseng group 
experienced significant reductions in plasma creatine kinase compared to the placebo group at 72 
hours post-exercise. Additionally, at two and three hours following exercise, there were 
significant reductions in plasma interleukin-6 (IL-6), which is a marker often used to assess 
muscle inflammation with demanding exercise vs the placebo group (Armstrong et al. 1983; 
Minetto et al. 2005; Ostrowski et al. 1999; Pedersen et al. 1998). Furthermore, blood glucose and 
insulin responses in the ginseng group were both attenuated following a oral glucose tolerance 
test suggesting improvements in insulin sensitivity. 
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Although interesting, this study also did not utilize any muscle strength testing, which as 
mentioned, has been said to be amongst the best methods to assess muscle damage (Warren et al. 
1999). Also, the huge 20 grams three times daily dose is not practical and may even bring about 
some undesirable side effects. Some of the adverse effects that have been associated with 
ginseng consumption include hypertension, difficulty sleeping, nausea, headache, nervousness, 
diarrhea, and fatigue (Miller. 1998; Vogler et al. 1999). Nevertheless, with more modest dosages 
it has been reported that “prolonged or excessive ginseng consumption involves very low risk to 
the user” (Chandler. 1988). Nevertheless, some degree of caution should still be exercised.   
Although ginseng of either the Asian or American variety might attenuate muscle damage 
in humans, the precise mechanism by which it is able to do this has not been established and 
needs to be studied further (Jung et al. 2011). In an in vivo study conducted on Wistar rats, 
ginseng was shown to attenuate free radical production in skeletal muscle following exhaustive 
exercise (Voces et al. 2004), suggesting that anti-oxidant properties could explain how ginseng 
attenuates exercise induced muscle damage. Furthermore, in another rodent study, ginseng 
reduced lipid peroxidation through the inhibition of enzymes such as lipoxygenase (Cabral de 
Oliveira et al. 2001), which could explain its anti-inflammatory properties (Jung et al. 2011). A 
reduction in phospholipase A2 activity could also be responsible for ginseng’s anti-inflammaotry 
effects. (Liu and Chu. 1999).  
Other rodent data shows that ginseng can reduce nitric oxide in muscle following an 
eccentric exercise protocol (Cabral de Oliveira et al. 2005). Interestingly, nitric oxide can 
decrease the force of contraction of the diaphragm and ventricular myocytes (Joe et al. 1998). 
Moreover, low nitric oxide could function as an anti-oxidant, protecting muscles from any 
harmful effects of exhaustive exercise (Reid. 1998; Perez et al. 2002). Additionally, ginseng 
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might offer protection against mitochondrial membrane damage as well as reduce protein 
oxidation (Cabral de Oliveira et al. 2005). 
 
2.6 Factors Influencing Muscle Damage 
 Many exercise protocols can cause muscle damage. For example, lengthening (eccentric) 
contractions produce significant muscle damage vs shortening (concentric) contractions 
(Newham et al. 1983). Moreover, there are other factors that contribute to muscle damage, 
notably, the number of contractions, force, specific force and contraction velocity.  As the 
number of lengthening contractions is augmented, a greater amount of muscle damage occurs 
(Talbot and Morgan. 1998). Further, faster eccentric contractions result in greater muscle 
damage than slower velocities (Lieber and Friden. 1993). Their study demonstrated that the 
amount of strain on the muscle fibres and, not necessarily high forces, determine the extent of 
muscle damage. They stretched two groups of rabbit tibialis anterior muscle to the same degree 
and at the same velocity but in one group (early stretch), the stretch coincided with onset of 
muscle activation, while in the other group (long stretch), muscle stretch was commenced 200 
milliseconds after muscle activation. As a result, the muscles in the long stretch group generated 
a greater peak force than the early stretch group and despite the difference in force generation, 
the muscles in each group were damaged to a similar extent (Lieber and Friden. 1993). 
Furthermore, it has been shown that higher specific torque (higher frequency induced by 
electromyostimulation) resulted in more muscle damage than lower specific torque even when 
contraction velocity, range of motion, active muscle and contraction number were held constant 
(Black et al. 2008). 
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 Muscle biopsies in humans have shown evidence of disrupted sacromeres following 
eccentric contractions, especially at the z disks (Newham et al. 1983; Raastad et al. 2010; 
Lauritzen et al. 2009), which results in damage to cytoskeletal proteins critical for the integrity of 
the sacromere (Friden and Lieber. 2001).  With repetitive high intensity eccentric contractions, 
muscle damage is exacerbated as muscle fibre tension is increased resulting in damage to nearby 
z disks and sacromeres (Whitehead et al. 2003). 
 In addition to damage to the sacromeres, the mechanical stress to the muscle fibre may 
also cause damage to the excitation-contraction (EC) - coupling complex resulting in a reduction 
in force (Thiebaud. 2012). Specifically, it has been suggested that the EC- coupling complex is 
impaired precisely at the connection between the t-tubules and ryanodine receptors of the 
sarcoplasmic reticulum membrane, which are involved in mediating the release of calcium ions 
(Warren et al. 2001). In fact, data show that the junctophilin protein, which is a protein that 
enables a direct connection between the t-tubule and the ryanodine receptors, becomes impaired 
as a result of eccentric contractions and its damage is associated with a significant reduction in 
force (Corona et al. 2010).    
 Another mechanism involved in muscle damage is the activation of calcium proteases 
called calpains (Thiebaud. 2012). When ionic channels, such as stretch-activated calcium 
channels or transient receptor potential channels, are activated, there is an augmentation in 
intracellular calcium concentration (Allen et al. 2005). Further, elevated intracellular calcium 
occurs following the completion of eccentric contractions (Yeung et al. 2005).  Increases in 
intracellular calcium activate calpains, which can subsequently cleave proteins such as titin, 
desmin, nebulin, troponin, tropomyosin, kinases, and other signaling molecules causing 
additional damage to the muscle (Allen et al. 2005). Nevertheless, the precise role of calpains in 
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muscle damage is not fully understood, as there are also data showing that large increases in 
calpain activity following eccentric movements does not correlate well with impairment to the 
myofibrils (Raastad et al. 2010). As the number of damaged muscle fibers begin to accrue, 
inflammation increases and there is an infiltration of the neutrophils and macrophages into the 
muscle fibre (Pizza et al. 2002), which ultimately help to activate satellite cells leading to muscle 
repair (Tidball and Villalta. 2010). 
 In summary, muscle damage seems to result from mechanical stress placed on the 
sacromeres during eccentric muscle contractions, which ultimately causes strain to various 
components of the muscle fibre including cytoskeleton, z-discs, plasma membrane, sarcoplasmic 
reticulum, as well as the myofibril itself. Furthermore, this mechanical stress can lead to 
activation of stretch-activated calcium channels or transient receptor potential channels, which 
cause intracellular calcium to rise, stimulating calpains and resulting in additional damage to 
muscle fibre proteins and eventually, an inflammatory response. In the end, muscle damage will 
lead to attenuation in force production, muscle soreness, an increase in blood proteins, such as 
creatine kinase and myoglobin, and edema of the exercised body part (Thiebaud et al. 2012).   
 
2.7 Nutritional Supplements and the Attenuation of Exercise-Induced Muscle 
Damage 
 Previous data indicate that dietary carbohydrate and protein are helpful in attenuating the 
impairments in muscle function associated with exercise induced muscle damage (Cockburn et 
al. 2013) likely due to an enhancement of protein synthesis and attenuation of protein breakdown 
(Beelan et al. 2010) as well restoration of glycogen levels (Ivy. 1998).  Furthermore, a variety of 
nutritional supplements including ginseng have been studied for their role in the prevention and 
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treatment of exercise-induced muscle damage. An extensive review article on this topic is 
available (Bloomer 2007).  Relative to muscle damage induced by strength training, Bloomer 
concluded that the antioxidant vitamin C when taken alone as well as together with the 
antioxidant vitamin E may have the ability to reduce markers of muscle damage in untrained 
people. Further, flavonoids, when taken with mixed tocopherols and docosahexanoate, attenuate 
markers of inflammation in the untrained population, but did not have an effect on other markers 
of muscle damage. Also, there is a study reporting that branched chain amino acids (BCAA) (1 g 
isoleucine,  2.3 g leucine, 1.2 g valine) taken 15 minutes prior to exercise reduced delayed onset 
muscle soreness (DOMS) in women but not in men, perhaps due the lower relative dosage given 
to the men (Shimomura et al. 2006). Finally, there are data showing that HMB (β-hydroy-β-
methylbutyrate) taken at the same time as full body resistance training may be able to reduce 
creatine kinase and protein breakdown (as measured by urinary 3-methylhistidine) in untrained 
men, however, the fact that the subjects also ingested protein in addition to HMB may have 
confounded the results (Nissen et al. 1996).   
In the strength-trained population, vitamin E can reduce creatine kinase (McBride et al. 
1998) and L-carnitine can attenuate creatine kinase release, muscle soreness as well as tissue 
damage that was evaluated via an MRI (Volek et al. 2002). It was speculated that supplemental 
carnitine may possess antioxidant properties as well as the ability to help one maintain normal 
blood flow (Bloomer et al. 2007).  Nevertheless, the evidence for all these nutrients is scarce due 
to the small number of participants studied (Bloomer. 2007).      
 Furthermore, in order for the nutritional supplements to have any effect, they may need to 
be ingested for days or weeks before the exercise, however, an ideal pretreatment time period has 
yet to be established nor is there much data comparing supplements consumed pre-exercise 
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versus post-exercise (or during exercise for that matter). Moreover, due to lack of data, the 
optimal dosage of these nutrients is unknown as is the effect that several of these nutrients used 
in conjunction would have on muscle damage (Bloomer. 2007). 
Bloomer also mentioned that with the exception of L-carnitine, the effectiveness of many 
of these nutritional supplements is specific to non-resistance trained individuals (Bloomer. 
2007). There are some data showing 1200 IU (international units) per day of vitamin E taken 2 
weeks prior to exercise was able to attenuate creatine kinase release in strength-trained men 
(McBride et al. 1998). Also, two grams per day of L-carnitine taken for 3 weeks prior to exercise 
and four days in recovery reduced serum creatine kinase concentration, muscle soreness, and 
tissue damage, the latter being determined via an MRI, in strength-trained men (Volek et al. 
2002). Moreover, a recent study showed that L-glutamine supplementation was able to attenuate 
post-exercise strength loss and muscle soreness in physically active men who performed drop 
jumps (Street et al. 2011).  It should be noted that no supplement studied to date has been able to 
eliminate exercise-induced muscle damage, but some appear to attenuate its effects (Bloomer. 
2007).  
  
2.8 The Repeated Bout Effect 
 When unaccustomed exercise or exercise that is of a much greater volume, duration 
and/or intensity than done routinely is performed, the result is often muscle pain and weakness 
that is experienced for several days following the exercise (Nosaka and Aoki. 2011).  Delayed 
onset muscle soreness (DOMS) and an extended loss of muscle function are common symptoms 
of muscle damage that is caused by eccentric contractions or isometric contractions at a long 
muscle length (Nosaka. 2008). However, when the same or a similar exercise is repeated within a 
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time frame of several weeks, even if no exercises are done in between, there is a significantly 
reduced or absence of pain felt post-exercise, which previously caused DOMS. This is known as 
the repeated bout effect (Nosaka. 2008; Nosaka. 2010). 
 One of the priorities of the present study is to cause DOMS through a downhill running 
protocol so it is critical to know how long subjects need to refrain from doing any downhill 
running or similar form of exercise. Currently, there is some debate as to how long the repeated 
bout effect lasts. Some suggest that it can last several weeks to several months (Miyama and 
Nosaka. 2004). Significantly reduced changes and faster recovery of indicators of muscle 
damage were observed for 2-4 weeks (Newham et al. 1987), 6 weeks-6 months (Nosaka et al. 
1991), and 6 months (Nosaka et al. 2001).  Nevertheless, it should be pointed out that all these 
studies involved high intensity eccentric exercise of the elbow flexors and not the knee 
extensors, which were the muscles that were damaged in the current study. For the lower 
extremity muscles, the repeated bout effect has been shown to last 4-13 days (Mair et al. 1995) 
and 3 weeks (Brown et al. 1997).  Moreover, a downhill run study noted reduced muscle 
soreness and smaller increases in creatine kinase and myoglobin when a second bout of downhill 
running was repeated up to 6 weeks, but not 9 weeks following the first bout of downhill running 
(Byrnes et al. 1985). Also, a study involving drop jumps was shown to result in attenuated 
measures of muscle damage after the drop jumps were repeated 8 weeks following the initial 
bout of jumps (Miyama and Nosaka. 2004).  It believed that there is a direct relationship between 
the amount of muscle damage incurred in the initial bout of exercise and the protective effect 
observed after the subsequent bout (Miyama and Nosaka. 2004). Due to the fact that drop jumps 
result in more muscle damage than downhill running, it was expected that the repeated bout 
effect would last longer than 6 weeks, which it did.  For the present study involving bouts of 
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downhill running, we recruited participants who had not engaged in any extensive downhill 
endurance running in at least the previous 9 weeks. 
 One of the questions often associated with the repeated bout effect is exactly what are the 
mechanisms of this phenomenon? Although the precise mechanisms underlying the repeated 
bout effect have yet to be determined, a combination of mechanical, neural, and cellular 
adaptations are thought to play a role (McHugh et al. 1999; McHugh. 2003). The neural 
adaptations are said to consist of more efficient recruitment of motor neurons, increased 
synchrony of motor unit firing, better distribution of the workload among fibres, as well as an 
enhanced use of synergist muscles, and more slow-twitch fibre recruitment (Nosaka and Aoki. 
2011).   A repeated bout effect, consisting of attenuated muscle soreness and plasma creatine 
kinase concentration, was observed when comparing the first and second bout of electrically- 
stimulated isometric contractions of the knee extensors separated by two weeks (Aldayel et al. 
2009). This provides some evidence that the repeated bout effect can still occur without or with 
limited contribution from the central nervous system. More evidence for neural factors playing a 
role comes from data which showed indications of a carryover effect (Howatson and van 
Someren. 2007).  Howatson and van Someren reported that changes in muscle soreness, MVC 
strength, and serum creatine kinase activity were attenuated when a second bout of muscle 
damaging exercise was repeated on the contralateral arm 2 weeks later. Nevertheless, when 
comparing bout 1 and bout 2, the changes in muscle soreness and serum creatine kinase were 
greater in the ipsilateral group.  
 Others, however, feel that the underlying mechanisms of the repeated bout effect lie 
primarily within the muscle because one bout of muscle damaging exercise is not sufficient to 
cause alterations in neural drive (Kamandulis et al. 2010).  Furthermore, there is a study 
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involving voluntary versus electrically stimulating eccentric exercise of the knee extensors, 
which showed an equal repeated bout effect between the two groups, indicating that changes in 
muscle recruitment are not responsible for the repeated bout (Black and McCully. 2008).   
 Several other ideas that have been suggested to explain the repeated bout effect, which  
include mechanical adaptations, such as, increases in passive or dynamic muscle stiffness, 
remodeling of intermediate filament system, increased intramuscular connective tissue, as well 
as cellular adaptations, including, longitudinal addition of sarcomeres, inflammatory response 
changes, alterations to maintain excitation-contraction coupling, strengthened plasma membrane, 
increased protein synthesis, increased stress proteins, and/or removal of stress-susceptible fibers 
(Nosaka. 2010). Moreover, it has been suggested that muscle fibres may even be lengthened less 
during a subsequent bout of eccentric exercise, hence, resulting in less damage (Nosaka and 
Aoki. 2011).  Others have suggested that an upregulation of cytoskeletal protein and/or free 
radical scavenging pathways play a role in the repeated bout effect (Koh and Brooks. 2001).  
Further, the activation of the haemoxygenease-1 (HO-1) gene, caused by an augmentation in 
reactive oxygen and nitrogen species formation, may be related to the repeated bout effect 
(McArdle et al. 2004).  Regardless, with all this debate it is quite clear that further research is 
needed in order to explain the mechanisms responsible for the repeated bout effect.  
 
2.9 Tools to Measure Muscle Damage 
 They are a variety of methods that have been used to determine the extent of muscle 
damage including plasma creatine kinase concentration, muscle biopsies, magnetic resonance 
imaging (MRI), as well as assessments of muscle strength and function. Although creatine kinase 
has been widely used in the literature as a way to quantify muscle damage, there is some debate 
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in terms of its validity as a reflection of exercise-induced muscle damage (Baird et al. 2012). For 
example, some evidence suggests that creatine kinase by itself, may not offer a complete 
reflection of muscle damage (Mohaupt et al. 2009; Magal et al. 2010). Furthermore, there have 
been instances where reductions in creatine kinase did not result in similar decreases in delayed 
onset muscle soreness (McBride et al. 1998).  Also, another study found that despite a similar 
degree of muscle soreness and ultrastructure z-band damage amongst various groups of 
comparable male subjects, creatine kinase concentration was inconsistent across the groups 
(Fielding et al. 2000). Further, hydration status prior to muscle damaging exercise can have an 
effect on plasma creatine kinase. Limitations to creatine kinase have also been explained through 
the “balloon analogy,” which is based on the idea that if the air within a blown up balloon 
represented creatine kinase concentrations (with the balloon representing the sarcolemma) and a 
hole was poked in the balloon (representing muscle damage), all of the air (creatine kinase) 
would be released through the balloon (sarcolemma) and into the outside area (which in this 
analogy would represent the bloodstream. In other words, even a small amount of damage to a 
muscle can result in an amount of creatine kinase being released into the bloodstream that may 
not be much different from that released when a slightly greater amount of muscle damage is 
incurred. 
 Meanwhile muscle biopsies are limited when it comes to using them to help assess 
muscle damage. Due to the fact that biopsies are specific to a very small area of examination, 
they may not reflect the extent of damage to the entire muscle (Baird et al. 2012). In other words, 
extrapolation cannot always be utilized when it comes to muscle biopsies and muscle damage. 
Moreover, the biopsy itself may result in damage to the muscle (Baird et al. 2012). 
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 Muscle strength or function measures are another tool that has been used to assess the 
degree of damage to a muscle. It has been said that measures of muscle function, which were 
utilized in this study, may be the best way to determine the extent of exercise-induced muscle 
damage. Further in human studies, along with measurements of range of motion, measurements 
of maximal voluntary contraction torque may offer the best method to determine muscle injury 
(Warren et al. 1999). MRI is another method that can be used to evaluate muscle damage with 
elevated t2 relaxation times said to denote muscle damage (Leblanc et al. 2000). However, it 
involves considerable expense and consequently cannot be used routinely. 
 
2.10 Summary, Purpose and Hypothesis 
 There is evidence in both humans and rodents to suggest that ginseng is capable of 
exerting a variety of positive pharmacological effects, much of which has been attributed to its 
ginsenosides. Going forward, there needs to be additional human data on ginseng 
supplementation to establish the proper dosage, for which populations that ginseng is most 
appropriate, as well as to document any its potential beneficial effects.  
 This thesis is focused on investigating whether ginseng can attenuate exercise-induced 
muscle damage. Some human data suggest that ginseng is capable of doing this, however, these 
studies did not utilize any measurements of muscle strength, which may be one of the best 
practical method in assessing muscle damage (Warren et al. 1999) because more direct 
assessments of muscle damage are limited, i.e., sampling problems (biopsies) or expense (MRI). 
Therefore, the purpose of this study was to assess the effects of American ginseng on muscle 
damage in humans using an outcome measure (muscle strength) that has not been used 
extensively in previous ginseng studies.  The original plan was to use an aqueous ginseng extract 
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which in rodents reduced morphological signs of damage and inflammation compared to an 
alcohol extract (Estaki and Noble. 2012). However, this extract has not yet been approved for 
human use, so a Canadian grown American ginseng root powder (Rootalive Inc, Whitby, 
Ontario) was used in this study.  Consequently, it was hypothesized that four weeks of American 
ginseng supplementation in humans would not reduce indices of muscle damage following an 
acute bout of downhill running relative to a placebo.   
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3- METHODS 
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3.1 Participants 
 Ten men completed this study. An eleventh participant was unable to complete the study 
due to an injury to the calf and popliteal region of his leg, which was suffered in an activity 
separate from this research study.   Exclusion criteria included extensive downhill endurance 
running in the previous 9 weeks, medication for depression or blood thinners (such as warfarin), 
and any known metabolic, musculoskeletal or neurological diseases (had women been included 
in the study we would have excluded those who were pregnant).  This was verified using a 
previously approved health questionnaire (HSREB# 16912- see appendix 1) and having each 
participant complete the “Par Q and You Questionnaire” (Canadian Society for Exercise 
Physiology- see appendix 2).  All were instructed to avoid any nutritional supplementation 
(including vitamins and/or minerals) during the study. Despite this instruction, upon follow-up 
one subject in the ginseng group revealed that he consumed omega 3 supplements during the 
study. His data were still included in the study as they did not appear to be consistently different 
from the other subjects when looking at individual data pertaining to percent change from 
baseline measures and observing each of the time points amongst the three variations in muscle 
contraction. Further, it could be hypothesized that if omega 3’s were going to reduce muscle 
damage it would be through anti-inflammatory mechanisms. A recent review article stated that 
human data are inconclusive as to whether omega 3 polyunsaturated fatty acids are able to able 
to limit the inflammatory and immunomodulatory response to exercise when taken at the 
suggested dosage of approximately 1-2 g/d of EPA and DHA at a 2:1 EPA: DHA ratio.      
 Participants were able to continue their normal exercise routine, but were told not to add 
any new physical activity. The majority of participants were recreationally active, meaning that 
while they engaged in exercise (no endurance/downhill running), none were serious athletes 
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training  to maximize their athletic potential nor were any a member of a varsity team.  All 
possible risks or discomforts were explained fully prior to any testing and all participants 
provided written, informed consent. The study was conducted in the Exercise Research Nutrition 
Laboratory (ERNL) and the Wolf Orthopaedics Biomechanics Laboratory (WOBL).  Prior to any 
testing, the study was approved by the Office of Research Ethics at Western University. 
 
3.2 Experimental Overview 
This double-blind study commenced with participants reporting to the ERNL where they 
were debriefed regarding the nature of the study.  Participants proceeded to the WOBL for a 
familiarization day with the Biodex® (Biodex Medical Systems Incorporated, Shirley, NY) 
strength test device. Each replicated the protocol he would perform later during baseline and 
post-downhill run isometric and isokinetic leg extensor strength by going through the protocol 
once as a warm-up and then a second time giving a full effort. This familiarization day was 
conducted at least two days prior to performing baseline testing. The first four subjects in this 
study (two in each group) did not have a familiarization day and only performed submaximal 
contractions just prior to executing the baseline testing.  This was modified subsequently because 
it was felt that in order to minimize any learning effect from influencing the data performing 
maximal effort testing prior to baseline testing was best. Nevertheless, the data from the last six 
subjects were similar to the first four subjects so all baseline strength data were included.  
After the participants completed their baseline measures of leg extensor strength, they 
were given a supply of either American ginseng (450 mg capsules) or a placebo (500 mg inulin 
fibre) and instructed to take four capsules throughout the day (1.8 g/d) with food/meals for four 
the next weeks. Neither the researcher nor the participants knew who was given ginseng or 
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placebo in order to maintain the double blind nature of the study. This was done by having an 
individual not involved in the study label capsule containers with a code. The 1.8 g/d came out to 
24.5 mg/kg/d on average for the ginseng group. As for how this relative dosage compares to 
some other ginseng studies that involve animals, a rat study illustrated anti-oxidant effects of 
Panax ginseng extract when given at 10mg/kg or 100mg/kg daily for 3 months (Voces et al. 
2004) and an additional study concluded that Panax ginseng was able to protect muscle from 
injury induced by eccentric exercise in rats when given at a daily dosage of 100mg/kg daily for 3 
months (Cabral de Oliveira et al. 2005).  Meanwhile, the relative daily dosage in the American 
ginseng study in humans by Hsu et al. 2005 was, worked out to about 22.8 mg/kg daily, which 
was similar to the relative dosage used in this study.       
After four weeks of supplementation, participants reported back to the ERNL where they 
performed a downhill run on a treadmill broken up into five, eight minute running bouts (9.7-
11.3 km/h at -12% grade). One of the subjects was unable to complete the downhill running 
protocol having to stop midway through his third of the five, eight minute running bouts. His 
data were included in the study as his muscle strength results illustrated that he completed 
enough of the protocol to cause muscle damage. 
 At one, two and three days after the downhill run, participants repeated the Biodex® 
measures of leg extensor strength exactly as they had performed it four weeks earlier. 
Supplementation was continued during the post-run measures. Also, during each of these 
measurement times, participants rated their level of muscle soreness on a scale of one to ten with 
one representing virtually no soreness and ten representing the highest degree of pain or soreness 
(Maimer et al. 2012). Baseline soreness was assumed to be 1 as the participants had not done any 
recent eccentric exercise. Other studies that have involved subjects providing some sort of self 
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determination of muscle soreness have shown that subjects tend to provide quite low values of 
soreness at baseline (Leahy and Pintauro. 2013; Hilbert et al. 2003).  Participants also completed 
an incremental treadmill test and had their oxygen consumption ( V&O2max) as well as a body 
composition (lean mass and fat mass) via air displacement (Bod Pod®) densitometry (for details, 
see below). Further, a three day food record was completed by the participants, at a time which 
was convenient for them, whether that was prior to, during, or post ginseng or placebo 
consumption. The purpose of these were simply for descriptive data on the subjects.  
 
3.3 Strength Measures 
Isometric Peak Torque 
 Isometric peak torque of the dominant leg extensors was assessed using the Biodex® 
device in accordance with the manufacturer’s instructions both prior to and following 
supplementation. Briefly, isometric torque was assessed at a joint angle of 80 degrees because 
this knee angle has been demonstrated to elicit maximal torque values for isometric knee 
extensor exercise (Byrne et al. 2001). Participants performed three maximal voluntary 
contractions (MVC) of the quadriceps for five seconds with one min of rest between each one. 
The average peak torque of the three measures was recorded. Just prior to the MVC, participants 
performed a period of warm-up where they performed the same testing protocol, but using 
submaximal contractions at a self-selected effort level.   
 
Isokinetic Concentric Peak Torque 
 Measurements of isokinetic concentric peak torque of the knee extensors were conducted 
at angular velocities of 60 and 180 degrees/sec using the same Biodex® device as described 
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above. These testing speeds were based off a recent study published in the Journal of Strength 
and Conditioning Research by Nunan et al. 2010. Moreover, according to the Biodex® website, 
slow speeds (60-120 degrees/second) are considered “strength speeds” and fast speeds (180-300 
degrees) are known as “endurance speeds” (Biodex® Medical System Inc.). Hence, the two 
different testing speeds allowed us to assess muscle performance using two speeds that are 
categorically different.   
The isokinetic contractions were performed immediately following the isometric 
measures and the protocol entailed three maximal efforts conducted at each angular velocity and 
the average value was recorded. Participants performed three MVC consecutively at 60 
degrees/sec, followed by one minute of rest and then performed the three consecutive MVC at 
180 degrees/sec.  
 
3.4 Downhill Running Protocol 
 After four weeks of ginseng supplementation, the participants each performed an 
intermittent downhill running protocol on a treadmill, designed to elicit muscle damage (Eston et 
al. 2000; Nunan et al. 2010). Briefly, the downhill running protocol consisted of a total of 40 min 
of running divided into five, eight min bouts at between 9.7 and 11.3 kilometres per hour (6 and 
7 miles per hour) and -12% grade. Between the bouts of running subjects were permitted two 
minutes of active recovery (walking). Prior to the downhill run, participants were allowed to 
perform a five min self-paced warm-up at 0% grade. One participant chose not to perform the 
warm-up prior to the run. Subjects were permitted to have water ad libitum. 
 The -12% grade was verified as the inverse tangent ratio to determine the required angle 
of inclination. The inverse tangent of 12 divided by 100 is 6.8 degrees; hence, the back of the 
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treadmill was propped up and secured at this angle using pieces of wood (verified with an 
inclinometer).  
 
3.5 Body Composition 
 Body composition (lean mass and fat mass) was determined in the ERNL via whole body 
densitometry using air displacement plethysmography for volume and an accurate weigh scale 
for mass (Bod Pod®, Life Measurements, Concord, CA). Testing procedures were in accordance 
with the manufacturer’s instructions as detailed in the manual.  Briefly, the participants wore 
tight shorts (either compression shorts or boxer brief underwear) and a tightly fitted bathing cap 
on their head, thoracic gas volume was estimated for all participants through the use of a 
predictive equation essential to the Bod Pod® software, and all refrained from eating or 
exercising for at least two hours prior to the test.  Each participant’s height (cm) was determined 
prior to the body composition measurement using a double ruler body scale (Health o meter ®). 
All calculations were completed by system software. Body composition (as well as maximal 
oxygen uptake) measurements were done on the subjects only for descriptive data. 
 
3.6 Maximal Oxygen Uptake  
 Maximal oxygen uptake ( V&O2max) was determined in the ERNL with a Vmax® 
metabolic cart (V6200, Sensormedics Corporation, Yorba Linda, CA) using breath-by-breath 
measurements during an incremental graded running test on a Woodway® treadmill (Woodway 
USA Inc., Waukesha, WI).  Participants began the test at a comfortable running speed (9.7-11.3 
kilometres per hour) with a 0% incline. Each minute, the incline was increased 2% until 
volitional fatigue. Prior to the test, participants were instructed to go as long as they could and 
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taught how to safely get off the treadmill when they had reached volitional fatigue.  Data were 
averaged over 30 sec and the greatest value was taken as the V&O2max. Heart rate was monitored 
during the test using a Polar Wearlink®+ transmitter. 
 
3.7 Food Record 
 All participants in the study compiled a food diary in which they recorded everything 
they ate for three consecutive days. Four of the participants completed a food record on their 
own as it coincided with an academic assignment they were doing during the semester which 
required them to conduct a dietary analysis diet. The rest of the participants used a Taylor® 
(Taylor Precision Products, Las Cruces, NM) Classic Digital Kitchen Scale to use to weigh their 
food. From there, the food records were analyzed using the online program “eaTracker,” which 
was produced by Dietitians of Canada to calculate energy intake and macronutrient values. One 
subject did not complete a food record, but he did confirm that he did not alter his diet during his 
participation in the study. 
 
3.8 Ginseng and Placebo Capsules 
 The American Ginseng Vegi-Capsules consumed in the study were provided by 
Rootalive Inc., which is based in Whitby, Ontario. According to Rootalive, the capsules were 
formed from premium grade Canadian grown American Ginseng root and each capsule 
contained 450 mg. of 100% pure American ginseng, i.e., no fillers, yeast, binders, flow agents or 
preservatives were added to the capsules. They were not subject to any type of aqueous or 
alcohol extraction method and had a ginsenoside content of 5.53%. The American ginseng used 
in the study by Hsu and colleagues in 2005 had a ginsenoside composition of the following; 
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8.67% for Rb1, 0.99% for Rc, 1.05% for Rd, and 5.08% w/w (percent concentration weight/ total 
weight of solution) for Re (Hsu et al. 2005).   
 The placebo capsules used in this study were assembled In the ENRL using a Cap-M-
Quik® (S.L. Sanderson and Company, Berry Creek, CA) Size “1” Capsule Filler and size 1 
gelatin capsules (Empty Capsules Company, Murrieta, CA), capable of holding ~300 to 600 mg 
depending on the density of the powder. The capsules were filled with Life Brand® inulin fibre, 
which contained five calories and three grams of fibre per 3.2g teaspoon. Consequently, neither 
the energy nor the fibre would be expected to affect the placebo participants due to the minute 
quantities consumed.   
 
3.9 Statistical Analyses    
 Statistical analyses were performed using IBM SPSS Statistics. The strength measures 
were evaluated using a mixed factor 2 x 4 (treatment x time) repeated measures ANOVA. The 
ratings of perceived muscle soreness were evaluated using a mixed factor 2 x 3 (treatment x 
time) repeated measures ANOVA. Treatment by time interaction effects as well as main effects 
for group and time were assessed. Mauchly’s sphericity test was used to check the homogeneity 
of variance and when the assumption of sphericity was violated, it was corrected using the 
Greenhouse-Geisser adjustment. A significance level of p<0.05 was set prior to analyses and if a 
significant difference was identified, pairwaise comparisons with a Bonferroni correction were 
used to locate the difference. Furthermore, all values were reported as mean ± standard deviation 
values rounded to the nearest tenth, and the graphs were constructed using Microsoft Excel.  
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CHAPTER 4- RESULTS 
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4.1 Participant Data 
The men were approximately 21 years old and were similar in terms of height, body 
mass, VO2max, body fat as well as age (Table 1). There were no significant differences between 
the groups in any of the characteristics using one-way ANOVA and an alpha of p=0.05.  
Table 1. Physical characteristics of participants (means ± SD)  
Characteristic  Placebo n=5 Ginseng  n=5 P- value 
Age (y) 20.4 ± 2.3 21.4 ± 1.5  0.441 
Height (cm) 174.0± 6.2 174.8 ± 4.9 0.826 
Body mass (kg) 67.9 ± 13.7 73.4 ± 7.13 0.446 
 
V&O2max   ml.kg-1.min-1 58.2± 6.4 54.7 ± 7.9 0.458 
Body Fat (%) 11.1 ± 1.5 15.4 ± 5.6 0.136 
*Value significantly different from placebo (p<0.05)  
 
4.2 Self Rating of Muscle Soreness 
 There was a significant main effect for time (p < 0.01) on participants’ rating of their 
muscle soreness (muscle soreness on day 3 was significantly lower than both days 1 and 2, but 
there was no significant difference between days 1 and 2 post-run). There was no main effect for 
group (p=0.222) nor was there a group by time interaction effect (p=0.279) (Fig 2). One 
participant was unable complete the downhill running protocol but still complained of soreness 
in the days following it (ratings of 10, 9, and 7 on days 1, 2, and 3 respectively) so his data were 
included. Although baseline self ratings of muscle soreness were not actually taken, going by the 
aforementioned assumption that they would be quite low based on prior studies, it is reasonable 
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to expect that soreness values on each post-run day would be significantly greater than at 
baseline, particularly post-run  days 1 and 2.          
 
 
*Value significantly different from placebo (p<0.05). 
Figure 2. Perceived rating of muscle soreness one, two, and three days following the downhill 
run. A 1-10 rating scale was used with 1 representing the lowest or no soreness and 10 
representing the highest degree of soreness. Participants were able to select half values (i.e. 6.5).  
Values are mean ± SD for placebo (n=5) and ginseng (n=5) groups. There were no significant 
differences between groups. 
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4.3 Isometric Contractions 
  There was no main effect for group (p=0.478) nor was there a main effect for time. 
Although the p value for the effect of time was 0.021, once a Bonferroni correction was used on 
the pairwise comparisons it was determined that were no significant difference between any of 
the time points. Furthermore, there was no group by time interaction effect present (p=0.182). 
The overall pattern of response was similar between placebo and ginseng groups, which saw a 
decrease in force on post day 1, followed by a recovery on post days 2 and 3; however this trend 
was more evident in the ginseng compared to the placebo group, which was more consistent 
throughout (figure 3). In the placebo group, torque, in comparison to baseline values, decreased 
by 8.9± 15.4%, 2.3 ± 9.8, and 0.1 ± 15.1% on one, two, and three days after the downhill run 
respectively. In the ginseng group, torque decreased by 12.3 ± 15.6% compared to baseline one 
day following the downhill run, but then on days two and three following the run, it increased 4.2 
± 12.2% and 8.4 ± 8.2%, respectively.  All percentage data was calculated by analyzing each 
subject in each group’s individual percent change from baseline and tabulating the group means 
and standard deviations from those values.  
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*Value significantly different from placebo (p<0.05). 
 
Figure 3. Absolute peak torque values for isometric contractions of knee extensors. Torque was 
assessed at a knee angle of 80 degrees. Values are means ± SD for placebo (n=5) and ginseng 
(n=5). There were no significant differences between the groups. All torque values were 
measured in newton metres (N-M). 
 
4.4 Isokinetic Contractions at 60 Degrees/Second 
 The main effect of group was not significant (p=0.556) and neither was the main effect of 
time (p=0.219). There was also no group by time interaction either (p=0.542). Like the isometric 
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contractions, the overall blueprint for the ginseng group was similar and consisted of a decrease 
in force on post day 1 followed by a recovery on the next day and then maintenance on the third 
post run day. The data points in the placebo group exhibited less variability throughout.    In 
comparison to baseline values, torque in the placebo group decreased 2.2 ± 11.9% one day after 
the downhill run then subsequently increased 2±14.9% and 3.4± 18.4% on days two and three 
after the downhill run, respectively. Meanwhile, in the ginseng group, torque decreased each day 
after the run when compared to baseline with reductions of 12.5 ±13.5%, 5.8 ± 11%, and 7.4 ± 
6.5% on days one, two, and three respectively. There was no significant difference between the 
baseline measures of the two groups (Fig 4). 
 
*Value significantly different from placebo (p<0.05). 
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Figure 4. Absolute peak torque values for isokinetic contractions of knee extensors performed at 
a speed of 60 degrees per second. Values are means ± SD for placebo (n=5) and ginseng (n=5). 
There were no significant differences between the groups. All absolute torque values were 
measured in N-M.  
 
4.5 Isokinetic Contractions at 180 Degrees/Second  
 Once again, there was no main effect for group (p=0.735) nor time (p=0.179). There also 
was no group by time interaction effect present either (p= 0.893). The overall pattern of response 
mimics the ones seen in the other types of contractions in that in both groups there was a 
reduction in force on post day 1 followed by recovery and maintenance on the subsequent days. 
Data points were slightly less variable in the placebo group.  On the first day after the downhill 
run, the placebo group had a reduction in torque of 6.1 ± 11.7% compared to baseline then a 
subsequent increase of 0.7 ± 13.4% and 2.2 ±12.8% on days two and three, respectively. The 
ginseng group had a reduction of torque, relative to baseline, on all three days following the 
downhill run of 10.1 ± 10.4%, 3.1 ± 7.3%, and 1.7 ± 14.5% on days one, two and three days 
after, respectively. Once again, there was no significant difference in the baseline measures 
between the two groups (Fig 5).  
47 
 
 
 
 
*Value significantly different from placebo (p<0.05). 
 
 
Figure 5.  Absolute peak torque values for isokinetic contractions of knee extensors performed at 
a speed of 180 degrees per second. Values are means ± SD for placebo (n=5) and ginseng (n=5). 
All torque values were measured in N-M. 
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CHAPTER 5- DISCUSSION 
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5.1 Overview and Major Findings 
The purpose of this study was to investigate whether American ginseng supplementation 
in young men attenuates indices of muscle damage following a downhill running protocol, which 
was designed to initiate muscle damage. In order to accomplish this, muscle strength measures of 
the knee extensors as well as self-ratings of muscle soreness were studied in a double blind study 
(ginseng supplemented group vs a placebo group). The participants in the ginseng and placebo 
subjects were similar in terms of age, height, mass as well as in cardiovascular fitness ( V&O2 max) 
and body composition (body fat percentage).   
The downhill running protocol was effective in causing the subjects to experience a 
sensation of muscle soreness as evidenced by the ratings of perceived muscle soreness. This was 
expected because it is well established that exercise where eccentric contractions predominate, 
such as downhill running, causes muscle damage especially in those unaccustomed to that type 
of exercise (Clarkson and Newham. 1995).  Further, the numerical rating scale (NRS) used to 
assess soreness is “valid, reliable, and appropriate for use in clinical practice” (Williamson and 
Hoggart. 2005) and this type of rating scale has good sensitivity, produces data that are able to 
undergo a statistical analysis, and is highly reproducible (Brunelli et al. 2010). While these 
comments are in reference to the 11 point, 0-10 NRS, the 1-10 numeric rating scale that was 
employed in this study is essentially identical and has been used previously to assess subjective 
pain (Maimer et al. 2012).  Based on this rationale, the observed lack of significant difference 
between the ginseng and placebo groups in the measured self-ratings of muscle soreness suggests 
that the exercise protocol used induced a similar degree of muscle damage in both groups.  
Although there were no significant effects of time for peak torque at any point during the 
study, this may have been complicated by the large variability between subjects. For instance, for 
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the isometric contractions, at day 1 post-run, there was an 8.9 and 12.3% decrease in peak torque 
from baseline in the placebo and ginseng groups, respectively. In a study by Nunan et al. 2010, a 
comparable 9% decrease in peak torque in both a treatment and placebo group one day following 
a similar downhill running protocol was significant. Moreover, in the present study isokinetic 
contractions (60 degrees per second) on day 1 post-run reductions in peak torque of 2.2 and 
12.5% were observed in the placebo and treatment group, respectively compared to 7.5 and 5.8% 
in Nunan’s study.  For the isokinetic contractions (180 degrees/second), reductions in torque of 
6.1 and 10.1% were observed in the placebo and treatment group respectively compared to 7.4 
and 5.8% in Nunan’s study. All of these reductions were significant in Nunan’s study, while the 
present reductions were not likely due to the observed variability.  Consequently, it appears the 
present study was under powered.       
The gluteus muscles, quadriceps, and calf muscles were amongst the areas where subjects 
complained of soreness from the downhill running protocol. Moreover, there is a trend for 
subjects to experience deterioration in torque on the first day after the downhill run, albeit, non-
significantly (Figures 3-5). 
 
5.2 Limitations 
One of the limitations of this study was the large variability in the muscle strength 
measures amongst the subjects as well as a small n. Consequently, finding a between group 
effect was difficult. The data also suggest that there was also no effect of time on torque values 
of the knee extensors, but again, finding a difference was made difficult due to the large 
variability and limited participants. Furthermore, it is possible that a learning effect occurred in 
some of the subjects confounding the muscle damaging effects of the downhill run. Although a 
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familiarization protocol was in place, it may not have provided subjects with sufficient time to 
become accustomed to the machine. However, a similar study investigating the effects of beta-
hydroxy-beta-methylbutyrate and alpha-ketoisocaproic acid supplementation on exercise-
induced muscle damage used a warm-up protocol consisting of two sub-maximal contractions 
and one maximal contraction and did not mention a learning effect (Nunan et al. 2010). Also, 
there are data that have observed no learning effect with the Biodex® machine and mentioned it 
to be very reliable (Lund et al. 2005). Nevertheless, it is something to at least consider, especially 
when someone is naïve to performing a certain skill or protocol.  
Another possible limitation worth bringing up is the fact that there was some within 
group variability in the activity level of the subjects, which may explain at least some of the 
variation in decrements in average peak torque. Although the subjects in the study were 
unaccustomed to extensive downhill running, some subjects were less active than others and 
thus, may have been more susceptible than others to exercise-induced muscle damage. Another 
thing pertaining to the subjects worth mentioning are the food records, which in this study were 
only done to gain descriptive data on the subjects. In general, it has been shown that people have 
a tendency to underestimate their energy consumption (de Vries et al. 1994). 
An additional aspect of this study that turned out to be a limitation was the number of 
pills that the participants were instructed to ingest. The large number of daily pills (four) over an 
extended period of time resulted in some subjects forgetting to take a pill at some point during 
the course of the study. For the most part, the participants did follow directions and take the pills, 
however, several subjects had pills leftover at the conclusion of the study including one subject 
in the ginseng that had 31 pills that he did not consume. This means his dose was actually 1350 
mg/d not 1800mg as designed.  However, only his isokinetic contraction data at 60 
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degrees/second appeared to differ compared to the others.  Specifically, he experienced a much 
more severe reduction in force (32, 25, and 16% on days one, two, and three following the 
downhill run, respectively compared to the group average of 12, 6, and 7%). However, this 
subject was also the most unfit in the study and he was unable to complete the entire downhill 
running protocol, which may have contributed to the force drop off. Ironically, this subject had a 
larger recovery in force for the isokinetic contractions at 180 degrees/second on day 3 post 
downhill run (about 19% greater than baseline compared to the group average of -2%). 
Consequently, it is unlikely that this inconsistency resulted from the lower dosage.  
There were also three other subjects in the ginseng group that did not consume all their 
pills, (three, six, and 10 pills, respectively but any effect here would be minimal as missing 10 
pills over the study is only 4.5 g of a dose totaling 54 g). The placebo group had two subjects 
with pills leftover at the study conclusion (five and 11, respectively) and one subject who ran out 
prematurely.    
Another factor which likely played a role in the results is the type of ginseng used in this 
study.  One of the limitations that is present when studying ginseng is the difficulty in 
establishing a standardized version that can be used across various studies. The concentration of 
ginsenosides, the major active component in ginseng, as well as amount of individual 
ginsenosides in the plant can be altered by cultivation conditions, such as, soil, temperature, 
moisture, length of cultivation, and harvest season. Hence, ginseng could have differing effects 
depending on the location where it is cultivated (Yuan et al. 2002).  For instance, in a 
pharmacological study in rodents, extracts of American ginseng cultivated in the United States 
had greater inhibitory effects than American ginseng that was grown in China (Yuan et al. 1998). 
Additionally, American ginseng grown in the same country, but different locations has also been 
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shown to cause a variation in ginsenoside concentration. For example, aqueous extracts of 
American ginseng grown in the state of Illinois contained approximately 30% less of the 
ginsenoside Rb1 and 25% more ginsenoside Re than did American ginseng that was produced in 
the state of Wisconsin (Yuan et al. 2001).  
Additional challenges relate to the fact there can be variability in herbal products not only 
from manufacturer to manufacturer, but also from lot to lot (Winslow and Kroll. 1998). 
Furthermore, there have been discrepancies found between the ginsenoside concentration on 
ginseng labels and the ginseng concentration actually measured (Harkey et al. 2001).  
 
5.3 Is Exercise Induced Muscle Damage Beneficial or Detrimental? 
 Finally, another important consideration is even if ginseng is able to limit exercise-
induced muscle damage is this beneficial? Although exercise-induced muscle damage causes 
muscle soreness and a reduction in force production, it has been debated whether this damage 
and soreness is a necessary stimulus to cause beneficial adaptations such as muscle hypertrophy.  
In other words, if we were to attenuate muscle damage and alleviate muscle soreness post-
exercise, would we limit any adaptations to the prior workout? Some recent data suggest that 
post-exercise cold baths or cold water immersion, a common recovery modality used by athletes 
and fitness enthusiasts may help in recovery in the short-term but may hamper long term strength 
training adaptations, although the effects were said to be small (Fröhlich. 2014). Furthermore, 
there are data suggesting that muscle damage is needed to stimulate muscle hypertrophy. For 
instance, eccentric strength training is well-known to induce more muscle damage than 
concentric strength training and there is evidence that eccentric training may lead to greater gains 
in strength and muscle mass versus concentric strength training (Roig et al. 2009).  
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In contrast, while these studies suggest that eccentric exercise is superior to concentric 
exercise in terms of leading to muscle hypertrophy, it is critical to consider the total amount of 
work being performed (Thiebaud et al. 2012). Specifically, an intriguing study completed at 
McMaster University in Hamilton, Ontario (Moore et al. 2012) where muscle hypertrophy gains 
between eccentric and concentric strength training were compared when both total work and 
training intensity were matched is of interest. The eccentrically-contracted limb (elbow flexor) 
performed significantly more work than the concentrically-contracted limb per repetition (68 
kJ/rep vs 42 kJ/rep), so the concentrically-trained limb executed 40% more contractions in order 
to match the total work of the eccentrically contracted limb. After 9 weeks, the investigators 
concluded that when it comes to eccentric vs concentric resistance training, similar gains in 
muscle hypertrophy and strength can be achieved when training intensity and work output are 
matched. In other words, it is the exercise stimulus itself and not the nature of the contraction 
that produces gains in muscle strength and hypertrophy (Moore et al. 2012). 
Moreover, another study where muscle damage was induced in one group but not the 
other by using a recumbent ergometer with pedals that pushed toward the subject, thus allowing 
for eccentric contractions to occur is relevant. In this study, one group (pre-trained) underwent 
11 weeks of eccentric lower body strengthening, including 3 weeks of pre-training where 
intensity and duration were gradually increased, followed by 8 weeks where intensity and 
duration were maintained. The other group (naïve) was introduced to the training protocol in 
week four (meaning they only performed 8 weeks of eccentric lower body strengthening) and did 
not gradually increase their intensity and duration. Consequently in the first week, the naïve 
group experienced significant increases in plasma creatine kinase as well as a significantly 
greater degree of perceived muscle soreness, as measured using a visual analog scale. The total 
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cumulative workload completed by the two groups was matched even though the length of the 
protocols between the two groups was different (11 vs 8 weeks).   Importantly, after several 
weeks of training, no differences in muscle hypertrophy and strength were found between the 
two groups, evidence that one can obtain strength gains and muscle hypertrophy in the absence 
of significant muscle damage and soreness (Flann et al. 2011). 
Finally, a recent review paper concluded that muscle damage does not seem to be 
necessary to promote muscle hypertrophy, but that more studies examining microtears and 
molecular events that are not revealed through indirect markers such as creatine kinase, force and 
soreness are needed (Thiebaud. 2012). So, muscle damage may not be necessary in order to help 
muscle recover from a subsequent bout of similar exercise. In other words, the repeated bout 
effect (performing the same or similar exercise within a certain time frame results in less damage 
than the initial bout [McHugh et al. 1999; Nosaka et al. 2001; Nosaka. 2008; Nosaka. 2010]), 
may occur even if muscle damage does not occur in the initial exercise bout (Thiebaud. 2012), 
but it may be augmented with increasing amounts of muscle damage (Miyama and Nosaka. 
2004). 
 
5.4 Future Direction 
Future studies should include greater subject numbers as well as ensuring adequate 
familiarization of the strength testing equipment has occurred to eliminate any learning effects. 
Furthermore, future studies could benefit from having something that alerts subjects to take their 
daily pills as this may reduce the likelihood of subjects forgetting (perhaps an automated text 
alert). It would also be interesting to see prospective studies evaluate the validity of some of the 
health claims stated by ginseng marketers, such as, reduction in stress and fatigue, increase in 
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physical stamina, and reduction in severity of the common cold. As well, it would be ideal if 
future ginseng studies attempted to use a standardized version allowing better comparison across 
studies, however, as detailed earlier, this can be difficult.  
Of course, as it pertains to ginseng and muscle damage, future research should include 
the use of an aqueous ginseng extract with a higher ginsenoside yield, assuming that it meets 
safety guidelines, as well as larger sample sizes, and a combination of strength and blood plasma 
measures. Also an effort to standardize the diet of the participants as well as blood measures to 
assess how much of the ginsenosdies or other ginseng components were absorbed into the 
bloodstream could also be implemented in future research.   
Moreover, well downhill running has been shown to cause damage in the quadriceps, it 
has also been shown to cause damage to the gluteus muscles as well as the anterior and posterior 
tibial (shin and calf muscles respectively) muscles (Eston et al. 1994). Perhaps investigation on 
the extent of muscle damage in these other areas could be something worth examining in the 
future. A localized test for muscle soreness could also be something that could be utilized in the 
future to quantify the extent of muscle damage.  For instance, a spring-loaded pressure device on 
areas of damaged tissue could be used and participants could subsequently rate their level of 
muscle soreness on a numeric rating scale.   
The repetition of the baseline measures on different days could also be done in the future 
in order to evaluate the degree of biological variability amongst the subjects in the study in terms 
of the muscle strength measures. Magnetic resonance imaging (MRI) measures would also be 
helpful as they would provide an objective quantification of the damaged muscles so that the 
location and extent of the damage could be analyzed more completely. 
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5.5 Summary 
Ginseng has been said to have been utilized in some form for over 2000 years with the 
commonly held belief that it enhances life expectancy due to its ability to cure a wide variety of 
ailments (Yuan et al. 2002). For this study, it was hypothesized that four weeks of American 
ginseng supplementation, which had not undergone any extraction methods and consisted of only 
ground ginseng root, would be unable to reduce indices of muscle damage in young males 
following an acute bout of muscle damaging exercise, which in this case, was downhill running. 
The inability of this form of ginseng to attenuate signs of muscle damage was reflected by 
similar peak torque values of the knee extensor muscles during muscle strength measures 
consisting of isometric and isokinetic contractions between a ginseng consuming group and a 
placebo group. 
Ten young men completed this study and each of them underwent initial baseline testing 
consisting of muscle strength measures while consuming either American ginseng or placebo 
(inulin fibre) capsules for four weeks in addition to their normal daily diet. Following these four 
weeks, all participants performed a downhill running protocol designed to cause muscle damage 
and were then asked to repeat the initial muscle strength measures at one, two, and three days 
following the downhill run. The peak torque values for each of the three types of muscle 
contractions (isometric, isokinetic at 60 degrees/sec, isokinetic at 180 degrees/sec) were each 
analyzed separately and there were no significant differences found between the two groups, 
which coincided with the initial hypothesis. This suggests that ground American ginseng root is 
of little value when it comes to reducing muscle damage following a bout of eccentric exercise.  
 In general, a proper diet as well as post exercise consumption of carbohydrates and 
protein has also shown to be an asset to one’s recovery from exercise (Cockburn et al. 2013).  
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While some dietary supplements may reduce exercise induced muscle damage, this may not be 
the ideal option as not only does it appear that they need to be consumed for several days or 
weeks prior to the exercise in order to work (Bloomer. 2007), thus bringing about the potential 
risk of toxicity, but some supplements, such as vitamin C and E may actually hamper some 
beneficial adaptations to exercise such as improved insulin sensitivity by inhibiting the activation 
of ROS (reactive oxygen species) induced molecular regulators of insulin sensitivity, namely 
PGC 1α, PGC 1β, and PPARγ. (Ristow et al. 2009).  Vitamin C and E supplementation may also 
blunt endurance training induced rise in mitochondrial proteins, although vo2 max was 
unaffected. The exact mechanism for these results has yet to be specified (Paulsen. 2014). High 
intakes of antioxidants through supplementation may inhibit the body’s natural ability to adapt to 
oxidative stress (Peternelj and Coombes. 2011). Some data even suggest that dietary antioxidant 
supplements may raise markers of inflammation as opposed to reducing them (Peternelj and 
Coombs. 2011).  Hence, one should be cautious when choosing to consume nutritional 
supplements for whatever reason as more is certainly not always necessary and may even be 
detrimental.  
In the end, the best way to curb muscle damage or soreness following a bout of exercise 
is to perform an exercise that one is familiar with or has performed within the last several weeks 
in order to ensure that the repeated bout effect will occur. It is also essential that unaccustomed 
activities be introduced gradually if limiting post-exercise muscle soreness is a priority. As for 
ginseng, future studies focusing on larger sample sizes as well as the use of an aqueous extract 
would allow for further insight into its ability to attenuate exercise induced muscle damage.  
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Appendix A 
Participant Information 
 
Subject I.D.: ____________      Date: _________________ 
 
Age: ___________________   Height: _______________  Weight: _______________ 
 
Smoker:  Yes  /  No          Ethnic Background: _____________________ 
 
Medical History (please check any and all that apply) 
 
   Family history of heart disease  □ 
   Heart murmur     □ 
   Phlebitis     □ 
   Other heart disorder (please specify)  □ 
   Family history of stroke   □ 
   Migraines     □ 
   Sinus problems    □ 
   Hypertension     □ 
   Diabetes     □ 
   Raynaud’s syndrome    □ 
   Polycystic ovary syndrome   □ 
   Seizures     □ 
   Digestive problems    □ 
   Asthma     □ 
   Bronchitis     □ 
   Other respiratory disorder (please specify) □ 
    
Have you ever fainted?  Yes  /  No 
 
If yes, under what circumstances:  __________________________________________________ 
 
______________________________________________________________________________ 
 
Are you taking any medications? Yes  /  No 
 
If yes, please specify: ____________________________________________________________ 
 
Have you consumed alcohol or any caffeinated beverages in the last 12 hours? Yes  /  No 
 
If yes, please specify the quantity: __________________________________________________ 
 
Have you had any major surgeries, illnesses or injuries? Yes  /  No 
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If yes, please specify (include dates): _______________________________________________ 
 
Are you physically active?   Yes  /  No 
 
If yes, please specify the type, frequency, and typical duration of exercise: 
 
______________________________________________________________________________ 
 
How long have you been physically active? 
 
______________________________________________________________________________ 
 
Age of menarche:     __________________ 
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Appendix B 
http://www.csep.ca/cmfiles/publications/parq/par-q.pdf 
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Appendix C 
GINSENG AND EXERCISE 
The Effect of American Ginseng on Exercise-Induced Muscle Soreness 
  
We are currently looking for healthy 18-35 year old men and women to participate in a research study 
investigating the effects of American ginseng intake on exercise-induced muscle soreness. 
Measures: Muscle strength, muscle soreness ratings, and Magnetic Resonance Images before and after 
an exercise bout 
You can participate if you are: 
-18-35 years old 
-Healthy 
-Able to jog for 8 minutes  
-Have not engaged in any endurance run training in the previous 9 months 
You can NOT participate if you: 
-Are injured  
-Are diabetic 
-Have an upcoming surgery 
-Are pregnant or breast-feeding 
-Have insomnia or difficulty sleeping 
-Any history of head or eye injury involving medal fragments 
-Have some type of implanted electrical device (i.e. cardiac pacemaker) 
-Have severe heart disease including susceptibility to heart rhythm abnormalities 
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- Have conductive implants or devices such as skin patches, body piercing or tattoos containing metallic 
inks 
If you have questions about this study or would like to participate please contact Brent Smith  
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Appendix D 
Food Records- Energy and Macronutrient 3-Day Average Intakes (Rounded to Nearest Whole 
Number)  
Subject # Fat (g) Protein (g) Carbohydrate (g) Energy (kcal) 
1 109 110 244 2402 
2 119 193 366 3314 
3 120 137 318 2877 
4 72 102 326 2340 
5 93 82 321 2470 
6 29 76 273 1675 
7 48 131 228 1793 
8 80 292 217 2721 
9 N/A    
10 169 223 402 4090 
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Appendix E 
Certificate of Approval of Human Ethics 
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Appendix F 
Letter of Information 
Title of Study:  The effect of American ginseng on exercise-induced muscle soreness 
 
You are being invited to participate in a research study conducted by P.W.R. Lemon (PhD), 
Brent Smith (BA), Kole Abbott (BSc), Alan Smith (BSc), Terry Olver (MSc), Kristine Beaulieu (BSc), 
Adam Upshaw (MSc) and Arash Bandegan (MSc), from the Exercise Nutrition Research 
Laboratory in the School of Kinesiology at Western University.  
 
If you have any questions or concerns about the research, please feel free to contact Brent, 
Kole, Alan, Kristine, Terry, Adam, Arash or Dr. Lemon 
  
PURPOSE OF THE STUDY 
The purpose of this research is to determine if four weeks of American ginseng intake at 1800 
mg. per day will attenuate muscle soreness and/or injury following exercise. 
 
INCLUSION/EXCLUSION CRITERIA 
In order to be eligible to participate in this study you must be a healthy, 18 to 35 year old male 
or female who has not performed any endurance run training in the past 9 months.  
 
You will be excluded from this study if you report that you are: injured, diabetic, pregnant (or 
any chance you may become pregnant), breast-feeding, an insomniac, schizophrenic or if you 
are a female with endometriosis or uterine fibroids. Furthermore, you will also be excluded if 
you are taking warfarin, medication for diabetes or depression, have high or low blood 
pressure, or have surgery scheduled within two weeks following the completion of this study. 
 
PROCEDURES 
 If you volunteer to participate in this study, we will ask you to do the following things: 
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1. Complete a simple health survey (PAR-Q) to assess your current physical capability. 
2. Consume 1800 mg of American ginseng daily for four weeks leading up to a downhill jog 
test as well as throughout the time for post-run measures (a few days). 
3. Complete a downhill jog on a treadmill (similar to jogging down a small hill). This 
downhill test will consist of five, eight minutes bouts of jogging with two minutes of 
recovery (walking) in between each bout. 
4. Complete three, three second maximal static muscle contractions of the leg extensors 
(muscles that straighten the knee) and three maximal voluntary contractions at each of 
two different angular speeds (60 degrees/second and 180 degrees/second) using  a 
strength testing machine (Biodex) before and 24, 48, and 72 hours after the downhill jog 
test. 
5. A select few individuals will be asked to undergo an MRI (Magnetic Resonance Imaging) 
evaluation before and three days after the downhill run.  This involves lying on a bed in 
a confined space for about 20 minutes.  If you are selected for the MRI there additional 
exclusion criteria (see MRI section below).  
 
Testing will be conducted in the Exercise Nutrition Research Laboratory, Wolf Orthopaedic 
Biomechanics Laboratory, and St Joseph’s Health Care Centre at Western University. 
 
TIME INVOLVED 
This study will take place over the course of approximately four and a half weeks.  There will be 
a four week supplementation period, which will be followed by a 40 minute downhill jogging 
test (consisting of five, eight minute bouts with two minutes of walking recovery in between 
each bout) and four muscle strength testing sessions, three of which will take place at 24, 48, 
and 72 hours following the downhill run and the other will take place prior to beginning 
supplementation. 
 
Following the baseline measures of muscle strength on the Biodex, you will come to the 
Exercise Research Nutrition Research Lab for approximately to obtain your ginseng and to 
receive instructions about when to take it over the following 4.5 weeks (with meals).  The 
muscle strength tests, which will take a total of approximately 40 minutes to complete (10 
minutes on each of 4 test time points). Those that are selected to undergo the MRI will have 
two additional 20 minute assessment times (one prior to and one following the downhill run 
test). 
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POTENTIAL RISKS AND DISCOMFORTS 
All exercise involves some health risk (primarily heart/blood vessels or fluid-related) but lack of 
physical activity has been shown to more hazardous to one’s health.  Further, these concerns 
are much reduced in young, healthy individuals. Similar exercise to the type being used in this 
study is completed daily by Western students in kinesiology classes, in intramural sports, and by 
Mustang athletes.  Participants can expect to feel some muscle soreness from this experiment 
(similar to any unaccustomed exercise) which will resolve in a matter of days. You will be 
encouraged to drink additional fluids to replace any perspiration losses. 
  
American ginseng is generally considered safe and is widely available as an over the counter 
product in many grocery or health food stores throughout Canada. Many come with a GMP 
(good manufacturing practices) certification, which considers standard operating procedures, 
employee training, product specifications, expiration dating, vendor certifications and much 
more.  In terms of popularity, according to well-known botanist Dr. James Duke, America 
exports close to $100 million of American ginseng each year and about 6 million Americans use 
some form of ginseng regularly. However, there are some people who are best to avoid 
American ginseng (those people will be excluded for this study). Specifically, American ginseng 
use has been associated with insomnia, irritability, nervousness, or restlessness, but these 
effects are usually mild and transient. Further, there is some chance that this form of ginseng 
could cause low blood sugar when taken in large amounts. This is avoided if taken with meals 
which will be done in this study. The Biodex strength machine has been used widely here and 
around the world and there are no risks associated with it other than those associated with any 
exercise. 
 
MRI 
Some of you in this study will be asked to undergo an MRI (Magnetic Resonance Imaging) 
before and after the downhill running protocol. MRI is a common medical diagnostic tool that 
uses a strong magnetic field, a low frequency magnetic field, and a radio frequency field. No X-
rays are used. As with any technology there is a risk of death or injury. For MRI the risk of death 
is less than 1 in 10 million and the risk of injury is less than 1 in 100 000. These risks do not arise 
from the MRI process itself, but from a failure to disclose or detect MRI incompatible objects in 
or around the body of the subject or the scanner room. It is therefore very important that you 
answer all the questions honestly and fully on the MRI screening questionnaire. Almost all 
deaths and injuries related to MRI scans have occurred because the MRI operator did not know 
that surgically implanted metal hardware (such as a cardiac pacemaker) was present inside the 
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subject during the MRI scan. Other remote risks involve temporary hearing loss from the loud 
noise inside the magnet. This can be avoided with ear headphone protection that also allows 
continuous communication between the subject and staff during the scan. For comparison, the 
risk of death in an MRI is similar to travelling 10 miles by car, while the risk of injury during an 
MRI is much less than the risks associated with normal daily activities for one hour. Some 
examples that will prevent you from receiving an MRI include having some MRI incompatible 
metal in your body, being pregnant or attempting to become pregnant, or having a drug patch 
on your skin that contains metal foil. Should you require a medically necessary MRI scan in the 
future, the final decision as to whether you can be scanned will be made by a qualified 
physician considering all risks and benefits. 
 
MRI exclusion criteria 
 
If you have any history of head or eye injury involving metal fragments, if you have some type 
of implanted electrical device (such as cardiac pacemaker), if you have severe heart disease 
(including susceptibility to heart rhythm abnormalities), you should not have an MRI scan 
unless supervised by a physician. Additionally, you should not have a MRI scan if you have 
conductive implants or devices such as skin patches, body piercing or tattoos containing 
metallic inks because there is a risk of heating or induction of electrical currents within the 
metal element causing burns to adjacent tissue.   
 
POTENTIAL BENEFITS 
The results of this study will help to determine the effectiveness of American ginseng in humans 
on attenuating muscle soreness following downhill running. 
 
COMPENSATION 
You will not be compensated for your participation in this study. 
 
CONFIDENTIALITY 
Any information that is obtained in connection with this study that can identify you will remain 
confidential and will be disclosed only with your permission.  This information will be collected 
on a master list that will be kept in a password protected file with access to only the 
investigators in this study.  All data will be collapsed before results are printed (only group 
averages and variability).  All participants will be assigned an arbitrary number to ensure 
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anonymity.  Mean data will be stored in a password protected file for comparison with future 
studies.  Raw data will not be released to any other parties. 
 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you are a student and you volunteer, you 
may withdraw at any time without any effect on your status at Western.  If you are not a 
Western student, you may withdraw from the study at any time.  You may also refuse to 
answer any questions you feel are inappropriate and still remain in the study.  The investigator 
may withdraw you from this research if circumstances arise which warrant doing so. 
  
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
We plan to publish this study in a reputable academic journal upon the completion of the 
research.  The information published in a journal or subsequent studies will not identify you in 
any way.  Copies of such articles will be available upon request.  
 
 
SUBSEQUENT USE OF DATA 
These data may be used in subsequent studies but the data will have no personal identifiers.  
You will receive a copy of the consent form after it has been signed.  You do not waive any legal 
rights by signing the consent form. 
 
This letter is for you to keep.  If you have any questions about this research project, feel free to 
call us (Dr. Peter Lemon / Brent Smith, Kole Abbott, Alan Smith, Kristine Beaulieu, Terry Olver, 
Adam Upshaw, or Arash Bandegan) for clarification.  Further, if you have any questions about 
the conduct of this study or your rights as a research subject you may contact the Office of 
Research Ethics at Western University. 
 
Sincerely, 
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Dr. Peter Lemon / Brent Smith / Kole Abbott / Alan Smith / Kristine Beaulieu/ Terry Olver / 
Adam Upshaw / Arash Bandegan 
Principal Investigators  
RM 2235 3M Centre UWO, Exercise Nutrition Research Laboratory 
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Appendix G 
Letter of Informed Consent 
The effect of American ginseng supplementation on exercise-induced muscle soreness 
 
Investigator: P.W.R. Lemon (Brent Smith) 
    
I have read the accompanying "Letter of Information”, have had the nature of the study 
explained to me and I agree to participate.  All questions have been answered to my 
satisfaction. 
 
By signing below, I agree to participate in this study. 
                                                         
Name of Participant (please print): 
 
_______________________________________ 
   
Signature of Participant: 
 
______________________________      Date: ______________________ 
 
                                
Name of Person Obtaining Informed Consent: 
 
 _____________________________________ 
 
98 
 
 
 
Signature of Person Obtaining Informed Consent: 
 
________________________________    Date:  ______________________ 
 
  
RE-RECRUITMENT IN FUTURE STUDIES 
 
If you wish to participate in future studies in the Exercise Nutrition Research Lab, please include 
your current contact information below. 
 
 
I wish to be contacted for future studies in the Exercise Nutrition Research Laboratory. 
 
 
Yes_____ (check mark), No _____ (check mark)  
 
If yes, email __________________  Date: ______________________ 
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        London, Ontario 
           Kinesiology, B.A.  
         2006-2010 
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         London, Ontario 
             Kinesiology, M. Sc. 
          2010-2014 
 
Related Work Experience:     The University of Western Ontario 
        Graduate Teaching Assistant  
        2010-2011 
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